>
>
Polyclonal Antibodies Market Size - By Product (Primary Antibodies, Secondary Antibodies), Application, Route of Administration (IV, SC), Source (Rabbit, Goat, Mouse, Human), End-user, Global Forecast (2023-2032)
Download Free PDF
Polyclonal Antibodies Market
Get a free sample of this reportGet a free sample of this report Polyclonal Antibodies Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Buy Now
$4,123 $4,850
15% off
$4,840 $6,050
20% off
$5,845 $8,350
30% off
Buy now
Premium Report Details
Base Year: 2022
Companies covered: 12
Tables & Figures: 322
Countries covered: 19
Pages: 210
Download Free PDF
Polyclonal Antibodies Market Size
Polyclonal Antibodies Market size was valued more than USD 1.5 Billion in 2022 and is projected to grow at a CAGR of over 5.9% between 2023 and 2032. The rising incidence of chronic diseases such as cancer, autoimmune conditions, and infectious diseases anticipates propelling the industry demand. For instance, there were around 20 million new cancer cases, and the cancer burden is projected to rise by about 60% in the next two decades, reaching approximately 30 million new cases by 2040. This surge in cancer cases is expected to drive the demand for diagnostics and therapeutics.
Polyclonal antibodies are a group of antibodies that are produced by different B cells in the immune system. These antibodies are diverse and can recognize and bind to various epitopes (specific regions on an antigen) due to their origins from multiple B cell clones. Due to their broad epitope recognition, polyclonal antibodies are valuable tools in various applications, including diagnostics, therapeutics, and research.
COVID-19 Impact
The polyclonal antibodies industry experienced a substantial surge in 2020. Collaborative efforts involving pharmaceutical companies, research institutions, and governments played a pivotal role in expediting the manufacturing and distribution of polyclonal antibodies.. For instance, in a publication in the International Pathogens journal, GigaGen Inc. unveiled a peer-reviewed study detailing a recombinant polyclonal product engineered to combat SARS-CoV-2.
Polyclonal Antibodies Market Trends
Polyclonal Antibodies Market Analysis
Based on product, the market is segmented into primary antibodies and secondary antibodies. The secondary antibodies segment held the largest industry share at 66.4% in 2022.
Based on application, the polyclonal antibodies market is classified into diagnostics, therapeutics, and research. The diagnostics segment is expected to mark its dominance in 2022 accounting for the highest share of 59%.
Based on route of administration, the polyclonal antibodies market is classified into intravenous (IV), subcutaneous (SC), and other routes of administration. The intravenous (IV) segment is expected to exhibit CAGR of 5.3% by 2032.
Based on source, the market is categorized into rabbit, goat, mouse, human and other sources. In 2022, the rabbit segment accounted for USD 826.9 million revenue.
Based on end-users, the global polyclonal antibodies market is categorized into pharmaceutical & biotechnology companies, academic and research institutes, contract research Organizations (CROs), diagnostic laboratories and other end-users. The pharmaceutical & biotechnology companies segment led the industry share with a 45.9% in 2022.
In 2022, North America held a significant market share of 38.3% in the polyclonal antibodies market.
Polyclonal Antibodies Market Share
The polyclonal antibodies industry is characterized by the presence of leading key players such as Thermo Fisher Scientific, Abcam plc, and Bio-Rad Laboratories. These companies engage in strategic initiatives, including product launches, collaborations, and acquisitions, to strengthen their market positions.
Prominent market players operating in the industry is as mentioned below:
Polyclonal Antibodies Industry News:
The polyclonal antibodies market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:
Click here to Buy Section of this Report
By Product, 2018 – 2032 (USD Million)
By Application, 2018 – 2032 (USD Million)
By Route of Administration, 2018 – 2032 (USD Million)
By Source, 2018 – 2032 (USD Million)
By End-user, 2018 – 2032 (USD Million)
The above information is provided for the following regions and countries: